Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy
- 1 January 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (1) , 256-262
Abstract
Background and Purpose— Life-threatening intracranial hemorrhage, predominantly intracerebral hemorrhage (ICH), is the most serious complication of oral anticoagulant therapy (OAT), with mortality in excess of 50%. Early intervention focuses on rapid correction of coagulopathy in order to prevent continued bleeding. Summary of Review— This article reviews the epidemiology of OAT-associated ICH (OAT-ICH), and current treatment options, with the aim of providing a framework for future studies of unresolved questions. A number of acute treatments are available, but all have a significant risk of inducing thrombosis and other side effects, and vary in their rapidity of effect: vitamin K (very slow response time), fresh frozen plasma (slow response time, large volume of fluid required, transfusion-related acute lung injury), prothrombin complex concentrates, and recombinant activated factor VII. Current practice is to administer a combination of vitamin K and either fresh frozen plasma or prothrombin complex concentrates; the occasional use of recombinant activated factor VII has been reported. No prospective study has addressed the efficacy of, or outcomes from, the use of these practices. Conclusions— Current management of OAT-ICH is varied and not based on evidence from randomized controlled trials. Well-designed clinical trials are essential if we are to identify the effective acute treatments for OAT-ICH that are urgently needed.Keywords
This publication has 66 references indexed in Scilit:
- Clinical phenotypes and factor VII genotype in congenital factor VII deficiencyThrombosis and Haemostasis, 2005
- Recombinant Factor VIIa for Rapid Reversal of Warfarin Anticoagulation in Acute Intracranial HemorrhageMayo Clinic Proceedings, 2004
- Can Patients Be Anticoagulated After Intracerebral Hemorrhage?Stroke, 2003
- Stroke MRI in Intracerebral HemorrhageStroke, 2003
- The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective reviewAnnals of Allergy, Asthma & Immunology, 2002
- Hypoperfusion without Ischemia Surrounding Acute Intracerebral HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2001
- Incidence of intracerebral and subarachnoid haemorrhage in southern SwedenJournal of Neurology, Neurosurgery & Psychiatry, 2000
- The Overdosed Patient and Bleedings with Oral AnticoagulationSeminars in Thrombosis and Hemostasis, 1999
- VENOUS INFARCTION OF A TESTICLE FOLLOWING FACTOR IX CONCENTRATE (DEFIX)British Journal of Haematology, 1998
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997